Atossa Therapeutics, headquartered in Seattle, is welcoming two new medical directors to its staff. Kathy Puyana Theall, MD, is appointed Medical Director—Breast Oncology, and Adebola Giwa, MD, is now Medical Director—Rare Diseases. What Atossa Develops Atossa is a biopharmaceutical company that develops novel therapies in oncology and other rare diseases. Its lead product candidate, (Z)-Endoxifen, is currently in development in multiple clinical settings. The company intends for Theall an...